PMCID	SUBJECT_SCOPE_ID	S_START	S_END	SUBJECT_SCOPE	CONCEPT	IGNORANCE TYPE	C_START	C_END	CONCEPT_MENTION_ID
PMC1852384	PMC1852384_0	[0]	[254]	['Factors Affecting Morbidity and Mortality of Roux-en-Y Gastric Bypass for Clinically Severe Obesity: An Analysis of 1,000 Consecutive Open Cases by a Single Surgeon\n\nAbstract\n\nIntroduction\nDeterminants of perioperative risk for RYGB are not well defined.']	Gastric	UBERON_EXT	[55]	[62]	PMC1852384_T147
PMC1852384	PMC1852384_2	[454]	[582]	['Results\nOne hundred forty-six men, 854 women; average age 38.3\u2009±\u200911.2\xa0years; mean BMI 51.8\u2009±\u200910.5 (range 24–116) were evaluated.']	men	UBERON_EXT	[484]	[487]	PMC1852384_T148
PMC1852384	PMC1852384_2	[454]	[582]	['Results\nOne hundred forty-six men, 854 women; average age 38.3\u2009±\u200911.2\xa0years; mean BMI 51.8\u2009±\u200910.5 (range 24–116) were evaluated.']	women	NCBITAXON_EXT	[493]	[498]	PMC1852384_T114
PMC1852384	PMC1852384_2	[454]	[582]	['Results\nOne hundred forty-six men, 854 women; average age 38.3\u2009±\u200911.2\xa0years; mean BMI 51.8\u2009±\u200910.5 (range 24–116) were evaluated.']	women	UBERON_EXT	[493]	[498]	PMC1852384_T149
PMC1852384	PMC1852384_5	[691]	[793]	['The most common complications were incisional hernia 3.5%, intestinal obstruction 1.9%, and leak 1.6%.']	intestinal	UBERON_EXT	[750]	[760]	PMC1852384_T150
PMC1852384	PMC1852384_8	[879]	[1061]	['Logistic regression evaluating predictors of operative mortality correlated strongly with coronary artery disease (CAD) ( p \u2009<\u20090.01), sleep apnea ( p \u2009=\u20090.03), and age ( p \u2009=\u20090.042).']	coronary artery	UBERON_EXT	[969]	[984]	PMC1852384_T151
PMC1852384	PMC1852384_9	[1062]	[1176]	['BMI\u2009>\u200950 (0.6 vs 2.3%, p \u2009=\u20090.03) and male sex were associated with increased mortality (1.3 vs. 4.0%, p \u2009=\u20090.02).']	male	UBERON_EXT	[1100]	[1104]	PMC1852384_T152
PMC1852384	PMC1852384_10	[1177]	[1321]	['Sex-specific logistic regression demonstrated males with angiographically proven CAD were more likely to die ( p \u2009=\u20090.028) than matched cohorts.']	males	UBERON_EXT	[1223]	[1228]	PMC1852384_T153
PMC1852384	PMC1852384_10	[1177]	[1321]	['Sex-specific logistic regression demonstrated males with angiographically proven CAD were more likely to die ( p \u2009=\u20090.028) than matched cohorts.']	die	GO_BP_EXT	[1282]	[1285]	PMC1852384_T50
PMC1852384	PMC1852384_11	[1322]	[1417]	['Age ( p \u2009=\u20090.033) and sleep apnea ( p \u2009=\u20090.040) were significant predictors of death for women.']	death	GO_BP_EXT	[1401]	[1406]	PMC1852384_T51
PMC1852384	PMC1852384_11	[1322]	[1417]	['Age ( p \u2009=\u20090.033) and sleep apnea ( p \u2009=\u20090.040) were significant predictors of death for women.']	women	NCBITAXON_EXT	[1411]	[1416]	PMC1852384_T115
PMC1852384	PMC1852384_11	[1322]	[1417]	['Age ( p \u2009=\u20090.033) and sleep apnea ( p \u2009=\u20090.040) were significant predictors of death for women.']	women	UBERON_EXT	[1411]	[1416]	PMC1852384_T154
PMC1852384	PMC1852384_13	[1528]	[1611]	['Strategies employing risk stratification should be developed for bariatric surgery.']	bariatric	UBERON_EXT	[1593]	[1602]	PMC1852384_T155
PMC1852384	PMC1852384_14	[1613]	[1789]	['Introduction\nObesity is currently the number one public health problem in the United States, affecting one-third of all Americans (http:/www.surgeongeneral.gov/topics/obesity).']	Americans	NCBITAXON_EXT	[1733]	[1742]	PMC1852384_T116
PMC1852384	PMC1852384_16	[1895]	[2005]	['This obesity epidemic has been accompanied by a geometric rise in the number of bariatric surgical procedures.']	bariatric	UBERON_EXT	[1975]	[1984]	PMC1852384_T156
PMC1852384	PMC1852384_19	[2349]	[2611]	['The most common bariatric procedure performed in the United States is Roux-en-Y gastric bypass (RYGB).1\nThe explosive growth of bariatric surgery has garnered much attention in the media, with much speculation about the risks, both short- and long-term, of RYGB.']	gastric	UBERON_EXT	[2429]	[2436]	PMC1852384_T157
PMC1852384	PMC1852384_22	[2951]	[3194]	['More recently, Fernandez et al.3analyzed their patient cohort of 1,431 patients having open RYGB and found a 1.9% mortality, which was associated with age, weight, longer limb gastric bypass, and the occurrence of a leak or pulmonary embolism.']	limb	UBERON_EXT	[3122]	[3126]	PMC1852384_T158
PMC1852384	PMC1852384_22	[2951]	[3194]	['More recently, Fernandez et al.3analyzed their patient cohort of 1,431 patients having open RYGB and found a 1.9% mortality, which was associated with age, weight, longer limb gastric bypass, and the occurrence of a leak or pulmonary embolism.']	gastric	UBERON_EXT	[3127]	[3134]	PMC1852384_T159
PMC1852384	PMC1852384_22	[2951]	[3194]	['More recently, Fernandez et al.3analyzed their patient cohort of 1,431 patients having open RYGB and found a 1.9% mortality, which was associated with age, weight, longer limb gastric bypass, and the occurrence of a leak or pulmonary embolism.']	pulmonary	UBERON_EXT	[3175]	[3184]	PMC1852384_T160
PMC1852384	PMC1852384_24	[3391]	[3601]	['Materials and Methods\nBariatric Surgery Program The bariatric surgery program at St. Luke’s–Roosevelt Hospital Center in New York City was initiated in April 1999 and the first operation performed in June 1999.']	bariatric	UBERON_EXT	[3443]	[3452]	PMC1852384_T161
PMC1852384	PMC1852384_26	[3766]	[4111]	['Clinical Protocol and Surgical Technique All patients were evaluated preoperatively and met generally accepted criteria outlined by the NIH at its Consensus Development Conference on Gastrointestinal Surgery for Severe Obesity.4In addition, all patients were routinely evaluated by a registered dietitian experienced in the treatment of obesity.']	Gastrointestinal	UBERON_EXT	[3949]	[3965]	PMC1852384_T162
PMC1852384	PMC1852384_27	[4112]	[4265]	['Mental health and other specialty consultations were only obtained if they were felt to be clinically indicated or were required by an insurance carrier.']	Mental	UBERON_EXT	[4112]	[4118]	PMC1852384_T163
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	anesthesiologist	CHEBI_EXT	[4310]	[4326]	PMC1852384_T0
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	chest	UBERON_EXT	[4400]	[4405]	PMC1852384_T164
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	gallbladder	UBERON_EXT	[4413]	[4424]	PMC1852384_T165
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	serum	UBERON_EXT	[4442]	[4447]	PMC1852384_T166
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	electrolytes	CHEBI_EXT	[4448]	[4460]	PMC1852384_T1
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	glucose	CHEBI_EXT	[4462]	[4469]	PMC1852384_T2
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	calcium	CHEBI_EXT	[4478]	[4485]	PMC1852384_T3
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	lipid	CHEBI_EXT	[4496]	[4501]	PMC1852384_T4
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	liver	UBERON_EXT	[4511]	[4516]	PMC1852384_T167
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	blood	UBERON_EXT	[4542]	[4547]	PMC1852384_T168
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	platelets	CL_EXT	[4555]	[4564]	PMC1852384_T48
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	prothrombin	CHEBI_EXT	[4566]	[4577]	PMC1852384_T137
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	prothrombin	CHEBI_EXT	[4566]	[4577]	PMC1852384_T5
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	thromboplastin	CHEBI_EXT	[4592]	[4606]	PMC1852384_T6
PMC1852384	PMC1852384_28	[4266]	[4633]	['All patients were evaluated by an attending anesthesiologist before surgery.Routine preoperative studies included: electrocardiogram, chest x-ray, gallbladder ultrasonography, serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, prothrombin time, partial thromboplastin time, INR, and urinalysis.']	thromboplastin	PR_EXT	[4592]	[4606]	PMC1852384_T138
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	serum	UBERON_EXT	[4688]	[4693]	PMC1852384_T169
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	insulin	PR_EXT	[4694]	[4701]	PMC1852384_T139
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	iron	CHEBI_EXT	[4703]	[4707]	PMC1852384_T7
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	vitamin B12	CHEBI_EXT	[4719]	[4730]	PMC1852384_T8
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	vitamin B12	PR_EXT	[4719]	[4730]	PMC1852384_T140
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	25-OH	CHEBI_EXT	[4732]	[4737]	PMC1852384_T9
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	vitamin D	CHEBI_EXT	[4738]	[4747]	PMC1852384_T10
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	thiamine	CHEBI_EXT	[4753]	[4761]	PMC1852384_T11
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	vitamin B1	CHEBI_EXT	[4763]	[4773]	PMC1852384_T12
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	B1	PR_EXT	[4771]	[4773]	PMC1852384_T141
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	stomach	UBERON_EXT	[4914]	[4921]	PMC1852384_T170
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	antegastric	UBERON_EXT	[5013]	[5024]	PMC1852384_T171
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	gastrojejunostomy	UBERON_EXT	[5025]	[5042]	PMC1852384_T172
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	methylene blue	CHEBI_EXT	[5073]	[5087]	PMC1852384_T13
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	jejunojejunostomy	UBERON_EXT	[5161]	[5178]	PMC1852384_T173
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	GIA	UBERON_EXT	[5194]	[5197]	PMC1852384_T174
PMC1852384	PMC1852384_29	[4634]	[5394]	['Over time, additional preoperative studies, including serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1) were added.RYGB was performed in a standard fashion with the following common elements: (1) open technique; (2) 20–30\xa0ml pouch, nondivided stomach, TA 90B (US Surgical, Norwalk, CT, USA) applied twice; (3) hand-sewn two-layer retrocolic, antegastric gastrojejunostomy, 12\xa0mm in length, tested with methylene blue under pressure intraoperatively; (4) side-to-side, functional end-to-end jejunojejunostomy with dispSAble GIA (US Surgical) or LC (Ethicon Endosurgery, Sommerville, NJ, USA) 75\xa0mm staplers, and TA55 (US Surgical) or TX 60 (Ethicon Endosurgery) staplers and routinely oversewn with 3–0 silk Lembert sutures.']	TX	CHEBI_EXT	[5304]	[5306]	PMC1852384_T14
PMC1852384	PMC1852384_30	[5395]	[5570]	['The biliopancreatic limb-length measured 75\xa0cm along the antimesenteric border for patients with BMI less than 50 and 150\xa0cm for patients with BMI greater than or equal to 50.']	biliopancreatic	UBERON_EXT	[5399]	[5414]	PMC1852384_T175
PMC1852384	PMC1852384_30	[5395]	[5570]	['The biliopancreatic limb-length measured 75\xa0cm along the antimesenteric border for patients with BMI less than 50 and 150\xa0cm for patients with BMI greater than or equal to 50.']	limb	UBERON_EXT	[5415]	[5419]	PMC1852384_T176
PMC1852384	PMC1852384_31	[5571]	[5633]	['The Roux or alimentary limb-length was 150\xa0cm in all patients.']	alimentary	UBERON_EXT	[5583]	[5593]	PMC1852384_T177
PMC1852384	PMC1852384_31	[5571]	[5633]	['The Roux or alimentary limb-length was 150\xa0cm in all patients.']	limb	UBERON_EXT	[5594]	[5598]	PMC1852384_T178
PMC1852384	PMC1852384_32	[5634]	[5710]	['For the initial 14 cases, the stomach was divided using the GIA-100 stapler.']	stomach	UBERON_EXT	[5664]	[5671]	PMC1852384_T179
PMC1852384	PMC1852384_33	[5711]	[6008]	['This technique was abandoned and switched to the nondivided stomach after a stapler malfunction led to a leak.Closed suction drains were placed in all revisions, patients with BMI\u2009>\u200955, or if clinically indicated (e.g., identification of an intraoperative leak, technically difficult anastomosis).']	stomach	UBERON_EXT	[5771]	[5778]	PMC1852384_T180
PMC1852384	PMC1852384_35	[6054]	[6163]	['Fascia was closed with a running looped #1 PDS (Ethicon, Sommerville) and infiltrated with 0.25% bupivacaine.']	Fascia	UBERON_EXT	[6054]	[6060]	PMC1852384_T181
PMC1852384	PMC1852384_35	[6054]	[6163]	['Fascia was closed with a running looped #1 PDS (Ethicon, Sommerville) and infiltrated with 0.25% bupivacaine.']	bupivacaine	CHEBI_EXT	[6151]	[6162]	PMC1852384_T15
PMC1852384	PMC1852384_36	[6164]	[6374]	['The subcutaneous space was drained with a #10 Jackson–Pratt drain and the skin was closed with a running subcuticular stitch.The gallbladder was removed if gallstones were documented by preoperative ultrasound.']	subcutaneous	UBERON_EXT	[6168]	[6180]	PMC1852384_T182
PMC1852384	PMC1852384_36	[6164]	[6374]	['The subcutaneous space was drained with a #10 Jackson–Pratt drain and the skin was closed with a running subcuticular stitch.The gallbladder was removed if gallstones were documented by preoperative ultrasound.']	skin	UBERON_EXT	[6238]	[6242]	PMC1852384_T183
PMC1852384	PMC1852384_36	[6164]	[6374]	['The subcutaneous space was drained with a #10 Jackson–Pratt drain and the skin was closed with a running subcuticular stitch.The gallbladder was removed if gallstones were documented by preoperative ultrasound.']	subcuticular	UBERON_EXT	[6269]	[6281]	PMC1852384_T184
PMC1852384	PMC1852384_36	[6164]	[6374]	['The subcutaneous space was drained with a #10 Jackson–Pratt drain and the skin was closed with a running subcuticular stitch.The gallbladder was removed if gallstones were documented by preoperative ultrasound.']	gallbladder	UBERON_EXT	[6293]	[6304]	PMC1852384_T185
PMC1852384	PMC1852384_37	[6375]	[6718]	['Incisional or umbilical hernias were primarily repaired if encountered, oftentimes through a separate periumbilical incision.Invasive monitoring was not used routinely and Foley catheters were only placed if patients required invasive hemodynamic monitoring or in the case of revisions or when patients had multiple prior abdominal operations.']	umbilical	UBERON_EXT	[6389]	[6398]	PMC1852384_T186
PMC1852384	PMC1852384_37	[6375]	[6718]	['Incisional or umbilical hernias were primarily repaired if encountered, oftentimes through a separate periumbilical incision.Invasive monitoring was not used routinely and Foley catheters were only placed if patients required invasive hemodynamic monitoring or in the case of revisions or when patients had multiple prior abdominal operations.']	periumbilical	UBERON_EXT	[6477]	[6490]	PMC1852384_T187
PMC1852384	PMC1852384_37	[6375]	[6718]	['Incisional or umbilical hernias were primarily repaired if encountered, oftentimes through a separate periumbilical incision.Invasive monitoring was not used routinely and Foley catheters were only placed if patients required invasive hemodynamic monitoring or in the case of revisions or when patients had multiple prior abdominal operations.']	abdominal	UBERON_EXT	[6697]	[6706]	PMC1852384_T188
PMC1852384	PMC1852384_38	[6719]	[6843]	['Nasogastric tubes were left in placed as clinically indicated (intraoperative leak identified) or in patients with BMI\u2009>\u200955.']	Nasogastric tubes	UBERON_EXT	[6719]	[6736]	PMC1852384_T189
PMC1852384	PMC1852384_39	[6844]	[7027]	['All patients received perioperative antibiotics for 24\xa0h, cefazolin (2\xa0g intravenously every 8\xa0h for three total doses) or clindamycin (900\xa0mg intravenously every 6\xa0h for four doses).']	antibiotics	CHEBI_EXT	[6880]	[6891]	PMC1852384_T16
PMC1852384	PMC1852384_39	[6844]	[7027]	['All patients received perioperative antibiotics for 24\xa0h, cefazolin (2\xa0g intravenously every 8\xa0h for three total doses) or clindamycin (900\xa0mg intravenously every 6\xa0h for four doses).']	cefazolin	CHEBI_EXT	[6902]	[6911]	PMC1852384_T17
PMC1852384	PMC1852384_39	[6844]	[7027]	['All patients received perioperative antibiotics for 24\xa0h, cefazolin (2\xa0g intravenously every 8\xa0h for three total doses) or clindamycin (900\xa0mg intravenously every 6\xa0h for four doses).']	clindamycin	CHEBI_EXT	[6967]	[6978]	PMC1852384_T18
PMC1852384	PMC1852384_40	[7028]	[7211]	['Prophylaxis against deep vein thrombosis consisted of 5,000 units of unfractionated heparin administered subcutaneously every 8\xa0h and pneumatic compression stockings until ambulatory.']	deep	UBERON_EXT	[7048]	[7052]	PMC1852384_T190
PMC1852384	PMC1852384_40	[7028]	[7211]	['Prophylaxis against deep vein thrombosis consisted of 5,000 units of unfractionated heparin administered subcutaneously every 8\xa0h and pneumatic compression stockings until ambulatory.']	vein	UBERON_EXT	[7053]	[7057]	PMC1852384_T191
PMC1852384	PMC1852384_40	[7028]	[7211]	['Prophylaxis against deep vein thrombosis consisted of 5,000 units of unfractionated heparin administered subcutaneously every 8\xa0h and pneumatic compression stockings until ambulatory.']	thrombosis	GO_BP_EXT	[7058]	[7068]	PMC1852384_T52
PMC1852384	PMC1852384_40	[7028]	[7211]	['Prophylaxis against deep vein thrombosis consisted of 5,000 units of unfractionated heparin administered subcutaneously every 8\xa0h and pneumatic compression stockings until ambulatory.']	heparin	CHEBI_EXT	[7112]	[7119]	PMC1852384_T19
PMC1852384	PMC1852384_40	[7028]	[7211]	['Prophylaxis against deep vein thrombosis consisted of 5,000 units of unfractionated heparin administered subcutaneously every 8\xa0h and pneumatic compression stockings until ambulatory.']	subcutaneously	UBERON_EXT	[7133]	[7147]	PMC1852384_T192
PMC1852384	PMC1852384_40	[7028]	[7211]	['Prophylaxis against deep vein thrombosis consisted of 5,000 units of unfractionated heparin administered subcutaneously every 8\xa0h and pneumatic compression stockings until ambulatory.']	ambulatory	GO_BP_EXT	[7200]	[7210]	PMC1852384_T53
PMC1852384	PMC1852384_43	[7389]	[7542]	['Patients with significant SA or documented CAD were usually observed in the recovery room overnight, and only rarely admitted to the intensive care unit.']	care	UBERON_EXT	[7532]	[7536]	PMC1852384_T193
PMC1852384	PMC1852384_44	[7543]	[7650]	['On the morning of postoperative day\xa01, patients were routinely studied with gastrograffin upper-GI studies.']	GI	UBERON_EXT	[7639]	[7641]	PMC1852384_T194
PMC1852384	PMC1852384_45	[7651]	[7829]	['If no leak was identified, they were given liquids for lunch and advanced to soft food (yogurt, apple sauce, and cottage cheese) for dinner and switched to oral pain medications.']	liquids	CHEBI_EXT	[7694]	[7701]	PMC1852384_T20
PMC1852384	PMC1852384_45	[7651]	[7829]	['If no leak was identified, they were given liquids for lunch and advanced to soft food (yogurt, apple sauce, and cottage cheese) for dinner and switched to oral pain medications.']	food	CHEBI_EXT	[7733]	[7737]	PMC1852384_T21
PMC1852384	PMC1852384_45	[7651]	[7829]	['If no leak was identified, they were given liquids for lunch and advanced to soft food (yogurt, apple sauce, and cottage cheese) for dinner and switched to oral pain medications.']	pain	GO_BP_EXT	[7812]	[7816]	PMC1852384_T54
PMC1852384	PMC1852384_45	[7651]	[7829]	['If no leak was identified, they were given liquids for lunch and advanced to soft food (yogurt, apple sauce, and cottage cheese) for dinner and switched to oral pain medications.']	medications	CHEBI_EXT	[7817]	[7828]	PMC1852384_T22
PMC1852384	PMC1852384_46	[7830]	[7875]	['Drains were usually removed before discharge.']	discharge	GO_BP_EXT	[7865]	[7874]	PMC1852384_T55
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	discharged	GO_BP_EXT	[7890]	[7900]	PMC1852384_T56
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	medications	CHEBI_EXT	[7949]	[7960]	PMC1852384_T23
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	codeine	CHEBI_EXT	[7964]	[7971]	PMC1852384_T24
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	prenatal	GO_BP_EXT	[7993]	[8001]	PMC1852384_T57
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	vitamins	CHEBI_EXT	[8002]	[8010]	PMC1852384_T25
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	iron polysaccharide	CHEBI_EXT	[8012]	[8031]	PMC1852384_T26
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	calcium citrate	CHEBI_EXT	[8033]	[8048]	PMC1852384_T27
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	ursodeoxycholic acid	CHEBI_EXT	[8050]	[8070]	PMC1852384_T28
PMC1852384	PMC1852384_47	[7876]	[8226]	['Patients were discharged on POD #2 or #3 as indicated with the following medications: a codeine-derivative for pain, prenatal vitamins, iron polysaccharide, calcium citrate, ursodeoxycholic acid, if the gallbladder was present.After hospital discharge, patients were scheduled to be seen at 2 and 8\xa0weeks, 6, 12, 18, 24\xa0months, and yearly thereafter.']	gallbladder	UBERON_EXT	[8079]	[8090]	PMC1852384_T195
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	serum	UBERON_EXT	[8347]	[8352]	PMC1852384_T196
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	electrolytes	CHEBI_EXT	[8353]	[8365]	PMC1852384_T29
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	glucose	CHEBI_EXT	[8367]	[8374]	PMC1852384_T30
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	calcium	CHEBI_EXT	[8383]	[8390]	PMC1852384_T31
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	lipid	CHEBI_EXT	[8401]	[8406]	PMC1852384_T32
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	liver	UBERON_EXT	[8416]	[8421]	PMC1852384_T197
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	blood	UBERON_EXT	[8447]	[8452]	PMC1852384_T198
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	platelets	CL_EXT	[8460]	[8469]	PMC1852384_T49
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	serum	UBERON_EXT	[8471]	[8476]	PMC1852384_T199
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	insulin	PR_EXT	[8477]	[8484]	PMC1852384_T142
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	iron	CHEBI_EXT	[8486]	[8490]	PMC1852384_T33
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	vitamin B12	CHEBI_EXT	[8502]	[8513]	PMC1852384_T34
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	B12	PR_EXT	[8510]	[8513]	PMC1852384_T143
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	25-OH	CHEBI_EXT	[8515]	[8520]	PMC1852384_T35
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	vitamin D	CHEBI_EXT	[8521]	[8530]	PMC1852384_T36
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	thiamine	CHEBI_EXT	[8536]	[8544]	PMC1852384_T37
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	vitamin B1	CHEBI_EXT	[8546]	[8556]	PMC1852384_T38
PMC1852384	PMC1852384_48	[8227]	[8559]	['All routine follow-up appointments included nutritional counseling and those after 2\xa0weeks included laboratory studies [serum electrolytes, glucose, HbA1c, calcium, albumin, lipid profile, liver function tests, complete blood count, platelets, serum insulin, iron, ferritin, vitamin B12, 25-OH vitamin D, and thiamine (vitamin B1)].']	vitamin B1	PR_EXT	[8546]	[8556]	PMC1852384_T144
PMC1852384	PMC1852384_51	[8805]	[9002]	['Data collected included: age, sex, height weight, BMI, race/ethnicity, payer status, obesity-related comorbidities, operative procedure, duration of stay, mortality, major complications, and death.']	death	GO_BP_EXT	[8996]	[9001]	PMC1852384_T58
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	venous	UBERON_EXT	[9073]	[9079]	PMC1852384_T200
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	thrombosis	GO_BP_EXT	[9080]	[9090]	PMC1852384_T59
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	pulmonary	UBERON_EXT	[9092]	[9101]	PMC1852384_T201
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	myocardial	UBERON_EXT	[9116]	[9126]	PMC1852384_T202
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	incisional	UBERON_EXT	[9170]	[9180]	PMC1852384_T203
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	intestinal	UBERON_EXT	[9189]	[9199]	PMC1852384_T204
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	GI	UBERON_EXT	[9243]	[9245]	PMC1852384_T205
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	anastomotic	UBERON_EXT	[9256]	[9267]	PMC1852384_T206
PMC1852384	PMC1852384_52	[9003]	[9302]	['Complications were classified as systemic (prolonged intubation, deep venous thrombosis, pulmonary embolism, and myocardial infarction/fatal arrhythmia) or technical (incisional hernia, intestinal obstruction, leak/perforation, dehiscence, GI bleeding, anastomotic stricture, and anastomotic ulcer).']	anastomotic ulcer	UBERON_EXT	[9283]	[9300]	PMC1852384_T207
PMC1852384	PMC1852384_53	[9303]	[9498]	['Deaths were analyzed with respect to BMI, demographics, comorbidities, and complications.Superficial wound infections were not included; the incidence of urinary tract infections was not tracked.']	Deaths	GO_BP_EXT	[9303]	[9309]	PMC1852384_T60
PMC1852384	PMC1852384_53	[9303]	[9498]	['Deaths were analyzed with respect to BMI, demographics, comorbidities, and complications.Superficial wound infections were not included; the incidence of urinary tract infections was not tracked.']	wound	UBERON_EXT	[9404]	[9409]	PMC1852384_T208
PMC1852384	PMC1852384_53	[9303]	[9498]	['Deaths were analyzed with respect to BMI, demographics, comorbidities, and complications.Superficial wound infections were not included; the incidence of urinary tract infections was not tracked.']	urinary tract	UBERON_EXT	[9457]	[9470]	PMC1852384_T209
PMC1852384	PMC1852384_54	[9499]	[9842]	['Nutritional complications were not evaluated because all patients were routinely maintained on vitamins, iron, and calcium supplements postoperatively; it would be impossible to determine the true incidence of any of these nutritional deficiencies.Univariate analyses and logistic regression with SPSS 11.0 were used to determine significance.']	vitamins	CHEBI_EXT	[9594]	[9602]	PMC1852384_T39
PMC1852384	PMC1852384_54	[9499]	[9842]	['Nutritional complications were not evaluated because all patients were routinely maintained on vitamins, iron, and calcium supplements postoperatively; it would be impossible to determine the true incidence of any of these nutritional deficiencies.Univariate analyses and logistic regression with SPSS 11.0 were used to determine significance.']	iron	CHEBI_EXT	[9604]	[9608]	PMC1852384_T40
PMC1852384	PMC1852384_54	[9499]	[9842]	['Nutritional complications were not evaluated because all patients were routinely maintained on vitamins, iron, and calcium supplements postoperatively; it would be impossible to determine the true incidence of any of these nutritional deficiencies.Univariate analyses and logistic regression with SPSS 11.0 were used to determine significance.']	calcium	CHEBI_EXT	[9614]	[9621]	PMC1852384_T41
PMC1852384	PMC1852384_55	[9844]	[9902]	['Results\nThe population consisted of 854 women and 146 men.']	women	NCBITAXON_EXT	[9884]	[9889]	PMC1852384_T117
PMC1852384	PMC1852384_55	[9844]	[9902]	['Results\nThe population consisted of 854 women and 146 men.']	women	UBERON_EXT	[9884]	[9889]	PMC1852384_T210
PMC1852384	PMC1852384_55	[9844]	[9902]	['Results\nThe population consisted of 854 women and 146 men.']	men	NCBITAXON_EXT	[9898]	[9901]	PMC1852384_T118
PMC1852384	PMC1852384_55	[9844]	[9902]	['Results\nThe population consisted of 854 women and 146 men.']	men	UBERON_EXT	[9898]	[9901]	PMC1852384_T211
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	WomenMenTotal	UBERON_EXT	[10115]	[10128]	PMC1852384_T212
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	Women	NCBITAXON_EXT	[10591]	[10596]	PMC1852384_T119
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	Women	UBERON_EXT	[10591]	[10596]	PMC1852384_T213
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	Men	NCBITAXON_EXT	[10612]	[10615]	PMC1852384_T120
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	menses276	UBERON_EXT	[11010]	[11019]	PMC1852384_T214
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	coronary artery	UBERON_EXT	[11039]	[11054]	PMC1852384_T215
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	heart	UBERON_EXT	[11074]	[11079]	PMC1852384_T216
PMC1852384	PMC1852384_58	[10040]	[11269]	['Caption (TABLE-WRAP): TABLE\xa01\n\nDemographic Characteristics by Sex and Race\xa0WomenMenTotal p -ValueAge (years)38\u2009±\u20091.0 (15–73)40\u2009±\u200911.9 (15–65)38\u2009±\u200911.17 (15–73)0.064Weight (kg)134\u2009±\u200927 (84–263)170\u2009±\u200943 (81–345)139\u2009±\u200933 (82–345)<0.01BMI (kg/m2)51\u2009±\u200910 (35–1,000)55\u2009±\u200913 (24–116)51\u2009±\u200910 (24–116)<0.01Caucasian(28%) 238/853(53%) 78/14732%<0.01African–American(30%) 253/853(20%) 29/14728%0.01Hispanic(42%)358/853(27%)40/14740%<0.01Other(0.5%) 4/853(0%) 0/1470.4%0.41\n\nCaption (TABLE-WRAP): TABLE\xa02\n\nPrevalence of Obesity-Related Comorbid Conditions by Sex\xa0Women ( N \u2009=\u2009853) (%)Men ( N \u2009=\u2009147) (%)Total (%) p -ValueType II diabetes mellitus177 (21)54 (37)23<0.01Hypertension310 (36)79 (54)39<0.01CAD/CHF29 (3)26 (18)6<0.01Dyslipidemia376 (44)80 (54)470.02Sleep apnea172 (20)63 (43)24<0.01Asthma135 (16)16 (11)150.12Dyspnea on exertion811 (95)127 (86)48<0.01GERD513 (60)77 (52)590.08Osteoarthritis791 (93)126 (87)92<0.01Urinary stress incontinence430/(50)5 (3)44<0.01Irregular menses276 (32)NA32NA\nCAD/CHF coronary artery disease/congestive heart failure, GERD gastroesophageal reflux disease\nThe most common comorbidites encountered were dyspnea on exertion (94%), joint pain/arthritis (92%), and gastroesophageal reflux disease (59%).']	joint	UBERON_EXT	[11199]	[11204]	PMC1852384_T217
PMC1852384	PMC1852384_61	[11527]	[11818]	['At time of initial evaluation, 13.0% of this diabetic patient subset had a prior history of insulin-dependent DM, 57.6% had noninsulin dependent DM, and 23% had a previous diagnosis of DM intermittently controlled on diet or were newly diagnosed with DM during their preoperative evaluation.']	insulin	PR_EXT	[11619]	[11626]	PMC1852384_T145
PMC1852384	PMC1852384_62	[11819]	[11994]	['Six percent of the patient population had angiographically documented histories of coronary artery disease (CAD) but were deemed suitable risk by their respective specialists.']	coronary artery	UBERON_EXT	[11902]	[11917]	PMC1852384_T218
PMC1852384	PMC1852384_63	[11995]	[12185]	['Procedures and Duration of Hospital Stay There were 966 primary RYGB and 34 revisions of failed bariatric procedures (21—VBG, 5—RYGB, 8—other; all performed at outside institutions) to RYGB.']	bariatric	UBERON_EXT	[12091]	[12100]	PMC1852384_T219
PMC1852384	PMC1852384_68	[12656]	[12786]	['The most common technical complications were incisional hernia (3.5%), intestinal obstruction (1.9%), and leak/perforation (1.6%).']	intestinal	UBERON_EXT	[12727]	[12737]	PMC1852384_T220
PMC1852384	PMC1852384_69	[12788]	[13513]	['Caption (TABLE-WRAP): TABLE\xa03\n\nIncidence of Complications after RYGBComplicationBMI\u2009<\u200950 (%) ( N \u2009=\u2009481)BMI\u2009>\u200950 (%) ( N \u2009=\u2009515)Total (%) p -ValueSystemic complicationsProlonged intubation3 (0.6)8 (1.5)1.10.16 (NS)Deep venous thrombosis0 (0)2 (0.4)0.2NSPulmonary embolism0 (0)3 (0.6)0.3NSMI/fatal arrhythmia1 (0.2)1 (0.2)0.2NSTechnical complicationsIncisional hernia10 (2.1)25 (4.8)3.50.019Intestinal obstruction10 (2.1)9 (1.7)1.9NSLeak7 (1.5)9 (1.9)1.6NSDehiscence2 (0.4)2 (0.4)0.4NSGI bleeding requiring transfusion3 (0.6)6 (1.2)0.9NSAnastomotic ulcer2 (0.4)0 (0)0.2NSAnastomotic Stricture6 (1.2)2 (0.4)0.8NSDeath4 (0.8)11 (2.1)1.5.03Thirty-one patients (3.1%) required reoperation within 30\xa0days of the original procedure.']	venous	UBERON_EXT	[13007]	[13013]	PMC1852384_T221
PMC1852384	PMC1852384_69	[12788]	[13513]	['Caption (TABLE-WRAP): TABLE\xa03\n\nIncidence of Complications after RYGBComplicationBMI\u2009<\u200950 (%) ( N \u2009=\u2009481)BMI\u2009>\u200950 (%) ( N \u2009=\u2009515)Total (%) p -ValueSystemic complicationsProlonged intubation3 (0.6)8 (1.5)1.10.16 (NS)Deep venous thrombosis0 (0)2 (0.4)0.2NSPulmonary embolism0 (0)3 (0.6)0.3NSMI/fatal arrhythmia1 (0.2)1 (0.2)0.2NSTechnical complicationsIncisional hernia10 (2.1)25 (4.8)3.50.019Intestinal obstruction10 (2.1)9 (1.7)1.9NSLeak7 (1.5)9 (1.9)1.6NSDehiscence2 (0.4)2 (0.4)0.4NSGI bleeding requiring transfusion3 (0.6)6 (1.2)0.9NSAnastomotic ulcer2 (0.4)0 (0)0.2NSAnastomotic Stricture6 (1.2)2 (0.4)0.8NSDeath4 (0.8)11 (2.1)1.5.03Thirty-one patients (3.1%) required reoperation within 30\xa0days of the original procedure.']	thrombosis0	GO_BP_EXT	[13014]	[13025]	PMC1852384_T61
PMC1852384	PMC1852384_69	[12788]	[13513]	['Caption (TABLE-WRAP): TABLE\xa03\n\nIncidence of Complications after RYGBComplicationBMI\u2009<\u200950 (%) ( N \u2009=\u2009481)BMI\u2009>\u200950 (%) ( N \u2009=\u2009515)Total (%) p -ValueSystemic complicationsProlonged intubation3 (0.6)8 (1.5)1.10.16 (NS)Deep venous thrombosis0 (0)2 (0.4)0.2NSPulmonary embolism0 (0)3 (0.6)0.3NSMI/fatal arrhythmia1 (0.2)1 (0.2)0.2NSTechnical complicationsIncisional hernia10 (2.1)25 (4.8)3.50.019Intestinal obstruction10 (2.1)9 (1.7)1.9NSLeak7 (1.5)9 (1.9)1.6NSDehiscence2 (0.4)2 (0.4)0.4NSGI bleeding requiring transfusion3 (0.6)6 (1.2)0.9NSAnastomotic ulcer2 (0.4)0 (0)0.2NSAnastomotic Stricture6 (1.2)2 (0.4)0.8NSDeath4 (0.8)11 (2.1)1.5.03Thirty-one patients (3.1%) required reoperation within 30\xa0days of the original procedure.']	fatal	GO_BP_EXT	[13079]	[13084]	PMC1852384_T62
PMC1852384	PMC1852384_69	[12788]	[13513]	['Caption (TABLE-WRAP): TABLE\xa03\n\nIncidence of Complications after RYGBComplicationBMI\u2009<\u200950 (%) ( N \u2009=\u2009481)BMI\u2009>\u200950 (%) ( N \u2009=\u2009515)Total (%) p -ValueSystemic complicationsProlonged intubation3 (0.6)8 (1.5)1.10.16 (NS)Deep venous thrombosis0 (0)2 (0.4)0.2NSPulmonary embolism0 (0)3 (0.6)0.3NSMI/fatal arrhythmia1 (0.2)1 (0.2)0.2NSTechnical complicationsIncisional hernia10 (2.1)25 (4.8)3.50.019Intestinal obstruction10 (2.1)9 (1.7)1.9NSLeak7 (1.5)9 (1.9)1.6NSDehiscence2 (0.4)2 (0.4)0.4NSGI bleeding requiring transfusion3 (0.6)6 (1.2)0.9NSAnastomotic ulcer2 (0.4)0 (0)0.2NSAnastomotic Stricture6 (1.2)2 (0.4)0.8NSDeath4 (0.8)11 (2.1)1.5.03Thirty-one patients (3.1%) required reoperation within 30\xa0days of the original procedure.']	ulcer2	UBERON_EXT	[13336]	[13342]	PMC1852384_T222
PMC1852384	PMC1852384_70	[13514]	[13949]	['The indications for reoperation within 30\xa0days were leak/perforation (11), intestinal obstruction (9), bleeding (4), rule-out leak (2), dehiscence (4), and subphrenic abscess (1).Indications for late operations (>30\xa0days postoperatively) included incisional hernia repair in 35 patients, intestinal obstruction in 10 patients, and repair of leaks/perforations in five patients who were experiencing ongoing postoperative complications.']	intestinal	UBERON_EXT	[13589]	[13599]	PMC1852384_T223
PMC1852384	PMC1852384_70	[13514]	[13949]	['The indications for reoperation within 30\xa0days were leak/perforation (11), intestinal obstruction (9), bleeding (4), rule-out leak (2), dehiscence (4), and subphrenic abscess (1).Indications for late operations (>30\xa0days postoperatively) included incisional hernia repair in 35 patients, intestinal obstruction in 10 patients, and repair of leaks/perforations in five patients who were experiencing ongoing postoperative complications.']	subphrenic	UBERON_EXT	[13670]	[13680]	PMC1852384_T224
PMC1852384	PMC1852384_70	[13514]	[13949]	['The indications for reoperation within 30\xa0days were leak/perforation (11), intestinal obstruction (9), bleeding (4), rule-out leak (2), dehiscence (4), and subphrenic abscess (1).Indications for late operations (>30\xa0days postoperatively) included incisional hernia repair in 35 patients, intestinal obstruction in 10 patients, and repair of leaks/perforations in five patients who were experiencing ongoing postoperative complications.']	intestinal	UBERON_EXT	[13802]	[13812]	PMC1852384_T225
PMC1852384	PMC1852384_71	[13950]	[14029]	['No patients required reoperation for refractory anastomatic stricture or ulcer.']	ulcer	UBERON_EXT	[14023]	[14028]	PMC1852384_T226
PMC1852384	PMC1852384_72	[14030]	[14175]	['One patient developed a gastrogastric fistula after repair of an early leak, which was treated expectantly since it was clinically insignificant.']	gastrogastric	UBERON_EXT	[14054]	[14067]	PMC1852384_T227
PMC1852384	PMC1852384_73	[14176]	[14223]	['No late gastrogastric fistulae were identified.']	gastrogastric fistulae	UBERON_EXT	[14184]	[14206]	PMC1852384_T228
PMC1852384	PMC1852384_74	[14224]	[14261]	['Deaths Thirty-day mortality was 1.2%.']	Deaths	GO_BP_EXT	[14224]	[14230]	PMC1852384_T63
PMC1852384	PMC1852384_76	[14314]	[14500]	['Patients with late deaths due to unrelated events, such as motor vehicle accidents ( N \u2009=\u20092) or drug overdoses ( N \u2009=\u20091), were excluded and not classified as mortalities in the analysis.']	deaths	GO_BP_EXT	[14333]	[14339]	PMC1852384_T64
PMC1852384	PMC1852384_76	[14314]	[14500]	['Patients with late deaths due to unrelated events, such as motor vehicle accidents ( N \u2009=\u20092) or drug overdoses ( N \u2009=\u20091), were excluded and not classified as mortalities in the analysis.']	drug	CHEBI_EXT	[14410]	[14414]	PMC1852384_T42
PMC1852384	PMC1852384_77	[14501]	[14747]	['Mortality correlated with BMI, with four (0.8%) patients having a BMI\u2009<\u200950 dying compared to 11 (2.1%) patients with BMI\u2009≥\u200950 ( p \u2009=\u20090.03) (Table\xa03).Causes of death after RYGB, along with their timing and relationship to BMI are shown in Table\xa04.']	Mortality	GO_BP_EXT	[14501]	[14510]	PMC1852384_T65
PMC1852384	PMC1852384_77	[14501]	[14747]	['Mortality correlated with BMI, with four (0.8%) patients having a BMI\u2009<\u200950 dying compared to 11 (2.1%) patients with BMI\u2009≥\u200950 ( p \u2009=\u20090.03) (Table\xa03).Causes of death after RYGB, along with their timing and relationship to BMI are shown in Table\xa04.']	dying	GO_BP_EXT	[14576]	[14581]	PMC1852384_T66
PMC1852384	PMC1852384_77	[14501]	[14747]	['Mortality correlated with BMI, with four (0.8%) patients having a BMI\u2009<\u200950 dying compared to 11 (2.1%) patients with BMI\u2009≥\u200950 ( p \u2009=\u20090.03) (Table\xa03).Causes of death after RYGB, along with their timing and relationship to BMI are shown in Table\xa04.']	death	GO_BP_EXT	[14660]	[14665]	PMC1852384_T67
PMC1852384	PMC1852384_78	[14748]	[14804]	['Two patients died of fatal arrhythmias on POD #3 and #4.']	died	GO_BP_EXT	[14761]	[14765]	PMC1852384_T68
PMC1852384	PMC1852384_78	[14748]	[14804]	['Two patients died of fatal arrhythmias on POD #3 and #4.']	fatal	GO_BP_EXT	[14769]	[14774]	PMC1852384_T69
PMC1852384	PMC1852384_79	[14805]	[14875]	['Both were males, ages 48 and 54, with BMIs\u2009>\u200950, DM, CAD, HTN, and SA.']	males	UBERON_EXT	[14815]	[14820]	PMC1852384_T229
PMC1852384	PMC1852384_81	[14971]	[15094]	['One patient, a 43-year-old woman with a BMI 59, died of a pulmonary embolism (identified at autopsy) at home after 2\xa0weeks.']	woman	NCBITAXON_EXT	[14998]	[15003]	PMC1852384_T121
PMC1852384	PMC1852384_81	[14971]	[15094]	['One patient, a 43-year-old woman with a BMI 59, died of a pulmonary embolism (identified at autopsy) at home after 2\xa0weeks.']	died	GO_BP_EXT	[15019]	[15023]	PMC1852384_T70
PMC1852384	PMC1852384_81	[14971]	[15094]	['One patient, a 43-year-old woman with a BMI 59, died of a pulmonary embolism (identified at autopsy) at home after 2\xa0weeks.']	pulmonary	UBERON_EXT	[15029]	[15038]	PMC1852384_T230
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	Deaths	GO_BP_EXT	[15152]	[15158]	PMC1852384_T71
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	deathEarly	GO_BP_EXT	[15182]	[15192]	PMC1852384_T72
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	20bowel	UBERON_EXT	[15324]	[15331]	PMC1852384_T231
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	Pulmonary	UBERON_EXT	[15399]	[15408]	PMC1852384_T232
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	multisystem	UBERON_EXT	[15424]	[15435]	PMC1852384_T233
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	organ	UBERON_EXT	[15436]	[15441]	PMC1852384_T234
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	died	GO_BP_EXT	[15462]	[15466]	PMC1852384_T73
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	gastrojejunostomy	UBERON_EXT	[15519]	[15536]	PMC1852384_T235
PMC1852384	PMC1852384_82	[15096]	[15617]	['Caption (TABLE-WRAP): TABLE\xa04\n\nCauses of Early and Late Deaths Related to BMICause of deathEarly (<30\xa0days) ( N \u2009=\u200911)Late (>30\xa0days) ( N \u2009=\u20094)BMI\u2009<\u200950BMI\u2009≥\u200950BMI\u2009<\u200950BMI\u2009≥\u200950MI/arrhythmia0200Pulmonary/PE0100MSOF 20leak1212MSOF 20bowel obstruction0100MSOF cause unknown1100Bleeding complications1200\nPE Pulmonary embolism, MSOF multisystem organ failureSix patients died from MSOF after postoperative leaks, three from the gastrojejunostomy and three from perforations of the distal small bowel within the common channel.']	small bowel	UBERON_EXT	[15579]	[15590]	PMC1852384_T236
PMC1852384	PMC1852384_84	[15727]	[15803]	['All four developed MSOF and expired between 14 and 211\xa0days postoperatively.']	expired	GO_BP_EXT	[15755]	[15762]	PMC1852384_T74
PMC1852384	PMC1852384_85	[15804]	[16078]	['Of the remaining two deaths, one patient, 46-year-old woman with a BMI 79 and a history of chronic ventilator dependence due to a paralyzed left hemidiaphragm on chronic steroid therapy developed a late leak and multiple intestinal fistulae and eventually succumbed to MSOF.']	deaths	GO_BP_EXT	[15825]	[15831]	PMC1852384_T75
PMC1852384	PMC1852384_85	[15804]	[16078]	['Of the remaining two deaths, one patient, 46-year-old woman with a BMI 79 and a history of chronic ventilator dependence due to a paralyzed left hemidiaphragm on chronic steroid therapy developed a late leak and multiple intestinal fistulae and eventually succumbed to MSOF.']	woman	NCBITAXON_EXT	[15858]	[15863]	PMC1852384_T122
PMC1852384	PMC1852384_85	[15804]	[16078]	['Of the remaining two deaths, one patient, 46-year-old woman with a BMI 79 and a history of chronic ventilator dependence due to a paralyzed left hemidiaphragm on chronic steroid therapy developed a late leak and multiple intestinal fistulae and eventually succumbed to MSOF.']	left	UBERON_EXT	[15944]	[15948]	PMC1852384_T237
PMC1852384	PMC1852384_85	[15804]	[16078]	['Of the remaining two deaths, one patient, 46-year-old woman with a BMI 79 and a history of chronic ventilator dependence due to a paralyzed left hemidiaphragm on chronic steroid therapy developed a late leak and multiple intestinal fistulae and eventually succumbed to MSOF.']	steroid	CHEBI_EXT	[15974]	[15981]	PMC1852384_T43
PMC1852384	PMC1852384_85	[15804]	[16078]	['Of the remaining two deaths, one patient, 46-year-old woman with a BMI 79 and a history of chronic ventilator dependence due to a paralyzed left hemidiaphragm on chronic steroid therapy developed a late leak and multiple intestinal fistulae and eventually succumbed to MSOF.']	intestinal fistulae	UBERON_EXT	[16025]	[16044]	PMC1852384_T238
PMC1852384	PMC1852384_86	[16079]	[16294]	['The other patient, a 43-year-old woman, BMI 43, had undergone a laparoscopic RYGB at another institution that was complicated by a strangulated internal hernia, massive intestinal gangrene, and short-bowel syndrome.']	woman	NCBITAXON_EXT	[16112]	[16117]	PMC1852384_T123
PMC1852384	PMC1852384_86	[16079]	[16294]	['The other patient, a 43-year-old woman, BMI 43, had undergone a laparoscopic RYGB at another institution that was complicated by a strangulated internal hernia, massive intestinal gangrene, and short-bowel syndrome.']	intestinal	UBERON_EXT	[16248]	[16258]	PMC1852384_T239
PMC1852384	PMC1852384_86	[16079]	[16294]	['The other patient, a 43-year-old woman, BMI 43, had undergone a laparoscopic RYGB at another institution that was complicated by a strangulated internal hernia, massive intestinal gangrene, and short-bowel syndrome.']	short	UBERON_EXT	[16273]	[16278]	PMC1852384_T240
PMC1852384	PMC1852384_86	[16079]	[16294]	['The other patient, a 43-year-old woman, BMI 43, had undergone a laparoscopic RYGB at another institution that was complicated by a strangulated internal hernia, massive intestinal gangrene, and short-bowel syndrome.']	bowel	UBERON_EXT	[16279]	[16284]	PMC1852384_T241
PMC1852384	PMC1852384_87	[16295]	[16636]	['She underwent a reversal of her RYGB with reconstruction of her GI tract, but developed multiple small bowel fistulae 2\xa0weeks postoperatively and died of MSOF several months later.Three patients died from a severe systemic inflammatory response syndrome (SIRS) with MSOF accompanied by extremely high fevers, without any identifiable source.']	GI tract	UBERON_EXT	[16359]	[16367]	PMC1852384_T242
PMC1852384	PMC1852384_87	[16295]	[16636]	['She underwent a reversal of her RYGB with reconstruction of her GI tract, but developed multiple small bowel fistulae 2\xa0weeks postoperatively and died of MSOF several months later.Three patients died from a severe systemic inflammatory response syndrome (SIRS) with MSOF accompanied by extremely high fevers, without any identifiable source.']	small bowel fistulae	UBERON_EXT	[16392]	[16412]	PMC1852384_T243
PMC1852384	PMC1852384_87	[16295]	[16636]	['She underwent a reversal of her RYGB with reconstruction of her GI tract, but developed multiple small bowel fistulae 2\xa0weeks postoperatively and died of MSOF several months later.Three patients died from a severe systemic inflammatory response syndrome (SIRS) with MSOF accompanied by extremely high fevers, without any identifiable source.']	died	GO_BP_EXT	[16441]	[16445]	PMC1852384_T76
PMC1852384	PMC1852384_87	[16295]	[16636]	['She underwent a reversal of her RYGB with reconstruction of her GI tract, but developed multiple small bowel fistulae 2\xa0weeks postoperatively and died of MSOF several months later.Three patients died from a severe systemic inflammatory response syndrome (SIRS) with MSOF accompanied by extremely high fevers, without any identifiable source.']	died	GO_BP_EXT	[16490]	[16494]	PMC1852384_T77
PMC1852384	PMC1852384_87	[16295]	[16636]	['She underwent a reversal of her RYGB with reconstruction of her GI tract, but developed multiple small bowel fistulae 2\xa0weeks postoperatively and died of MSOF several months later.Three patients died from a severe systemic inflammatory response syndrome (SIRS) with MSOF accompanied by extremely high fevers, without any identifiable source.']	inflammatory response	GO_BP_EXT	[16518]	[16539]	PMC1852384_T78
PMC1852384	PMC1852384_88	[16637]	[16752]	['One was a 70-year-old woman with BMI 68 underwent reexploration for an early postoperative small bowel obstruction.']	woman	NCBITAXON_EXT	[16659]	[16664]	PMC1852384_T124
PMC1852384	PMC1852384_88	[16637]	[16752]	['One was a 70-year-old woman with BMI 68 underwent reexploration for an early postoperative small bowel obstruction.']	small bowel	UBERON_EXT	[16728]	[16739]	PMC1852384_T244
PMC1852384	PMC1852384_89	[16753]	[16877]	['The others were a 54-year-old woman with a BMI 47, DM, HTN, and SA and a 37-year-old male with BMI 94 and severe SA and HTN.']	woman	NCBITAXON_EXT	[16783]	[16788]	PMC1852384_T125
PMC1852384	PMC1852384_89	[16753]	[16877]	['The others were a 54-year-old woman with a BMI 47, DM, HTN, and SA and a 37-year-old male with BMI 94 and severe SA and HTN.']	male	UBERON_EXT	[16838]	[16842]	PMC1852384_T245
PMC1852384	PMC1852384_91	[16969]	[17115]	['No intraabdominal or other sources were identified despite numerous cultures and radiologic studies.Three patients died of bleeding complications.']	intraabdominal	UBERON_EXT	[16972]	[16986]	PMC1852384_T246
PMC1852384	PMC1852384_91	[16969]	[17115]	['No intraabdominal or other sources were identified despite numerous cultures and radiologic studies.Three patients died of bleeding complications.']	died	GO_BP_EXT	[17084]	[17088]	PMC1852384_T79
PMC1852384	PMC1852384_92	[17116]	[17236]	['A 43-year-old woman with a BMI 48 suffered progressive hypotension and tachycardia in the recovery room postoperatively.']	woman	NCBITAXON_EXT	[17130]	[17135]	PMC1852384_T126
PMC1852384	PMC1852384_94	[17466]	[17598]	['A 31-year-old woman with a BMI 50 was returned to the OR 4\xa0h postoperatively for control of bleeding from the small bowel mesentery.']	woman	NCBITAXON_EXT	[17480]	[17485]	PMC1852384_T127
PMC1852384	PMC1852384_94	[17466]	[17598]	['A 31-year-old woman with a BMI 50 was returned to the OR 4\xa0h postoperatively for control of bleeding from the small bowel mesentery.']	control	GO_BP_EXT	[17547]	[17554]	PMC1852384_T80
PMC1852384	PMC1852384_94	[17466]	[17598]	['A 31-year-old woman with a BMI 50 was returned to the OR 4\xa0h postoperatively for control of bleeding from the small bowel mesentery.']	small bowel mesentery	UBERON_EXT	[17576]	[17597]	PMC1852384_T247
PMC1852384	PMC1852384_96	[17720]	[18005]	['A 54-year-old male with a BMI 56 and a history of HTN, CAD, and chronic atrial fibrillation suffered a postoperative myocardial infarction and developed a coagulopathy complicated by a massive intraspenic hematoma after restarting coumadin, which rapidly progressed to anuria and MSOF.']	male	UBERON_EXT	[17734]	[17738]	PMC1852384_T248
PMC1852384	PMC1852384_96	[17720]	[18005]	['A 54-year-old male with a BMI 56 and a history of HTN, CAD, and chronic atrial fibrillation suffered a postoperative myocardial infarction and developed a coagulopathy complicated by a massive intraspenic hematoma after restarting coumadin, which rapidly progressed to anuria and MSOF.']	myocardial	UBERON_EXT	[17837]	[17847]	PMC1852384_T249
PMC1852384	PMC1852384_96	[17720]	[18005]	['A 54-year-old male with a BMI 56 and a history of HTN, CAD, and chronic atrial fibrillation suffered a postoperative myocardial infarction and developed a coagulopathy complicated by a massive intraspenic hematoma after restarting coumadin, which rapidly progressed to anuria and MSOF.']	coumadin	CHEBI_EXT	[17951]	[17959]	PMC1852384_T44
PMC1852384	PMC1852384_96	[17720]	[18005]	['A 54-year-old male with a BMI 56 and a history of HTN, CAD, and chronic atrial fibrillation suffered a postoperative myocardial infarction and developed a coagulopathy complicated by a massive intraspenic hematoma after restarting coumadin, which rapidly progressed to anuria and MSOF.']	coumadin	PR_EXT	[17951]	[17959]	PMC1852384_T146
PMC1852384	PMC1852384_97	[18006]	[18202]	['Attempts to reverse his anticoagulation and control the bleeding angiographically were unsuccessful.The necessity for reoperation within 30\xa0days of the original procedure was particularly ominous.']	anticoagulation	GO_BP_EXT	[18030]	[18045]	PMC1852384_T81
PMC1852384	PMC1852384_97	[18006]	[18202]	['Attempts to reverse his anticoagulation and control the bleeding angiographically were unsuccessful.The necessity for reoperation within 30\xa0days of the original procedure was particularly ominous.']	control	GO_BP_EXT	[18050]	[18057]	PMC1852384_T82
PMC1852384	PMC1852384_98	[18203]	[18300]	['Overall, the incidence of death after a second operative procedure within 30\xa0days was 9/31 (29%).']	death	GO_BP_EXT	[18229]	[18234]	PMC1852384_T83
PMC1852384	PMC1852384_99	[18301]	[18456]	['Two of the 16 patients with a BMI\u2009<\u200950 who required reoperation within 30\xa0days died (12.5%) compared to 7 out of 15 patients with BMI\u2009≥\u200950 (47% p \u2009=\u20090.03).']	died	GO_BP_EXT	[18380]	[18384]	PMC1852384_T84
PMC1852384	PMC1852384_100	[18457]	[18614]	['This is similar to the mortality for the entire series where 0.8% for patients with a BMI\u2009<\u200950 died compared to 2.1% for patients with BMI\u2009≥\u200950 ( p \u2009=\u20090.03).']	died	GO_BP_EXT	[18552]	[18556]	PMC1852384_T85
PMC1852384	PMC1852384_101	[18615]	[18999]	['However, among those 15 patients classified as operative deaths for the entire series, 9 (60%) died after their second operative procedure.Logistic regression demonstrated that CAD [LR 7.5 p \u2009<\u20090.01 (95% CI 2.2 to 25.3)], and SA [LR 3.3 p \u2009=\u20090.03 (95% CI 1.1 to 10.1)], followed by age [LR 1.06 p \u2009=\u20090.042 (95% CI 1.00 to 1.12)], were risk factors for death in all patients (Table\xa05).']	deaths	GO_BP_EXT	[18672]	[18678]	PMC1852384_T86
PMC1852384	PMC1852384_101	[18615]	[18999]	['However, among those 15 patients classified as operative deaths for the entire series, 9 (60%) died after their second operative procedure.Logistic regression demonstrated that CAD [LR 7.5 p \u2009<\u20090.01 (95% CI 2.2 to 25.3)], and SA [LR 3.3 p \u2009=\u20090.03 (95% CI 1.1 to 10.1)], followed by age [LR 1.06 p \u2009=\u20090.042 (95% CI 1.00 to 1.12)], were risk factors for death in all patients (Table\xa05).']	died	GO_BP_EXT	[18710]	[18714]	PMC1852384_T87
PMC1852384	PMC1852384_101	[18615]	[18999]	['However, among those 15 patients classified as operative deaths for the entire series, 9 (60%) died after their second operative procedure.Logistic regression demonstrated that CAD [LR 7.5 p \u2009<\u20090.01 (95% CI 2.2 to 25.3)], and SA [LR 3.3 p \u2009=\u20090.03 (95% CI 1.1 to 10.1)], followed by age [LR 1.06 p \u2009=\u20090.042 (95% CI 1.00 to 1.12)], were risk factors for death in all patients (Table\xa05).']	CAD	GO_MF_EXT	[18792]	[18795]	PMC1852384_T112
PMC1852384	PMC1852384_101	[18615]	[18999]	['However, among those 15 patients classified as operative deaths for the entire series, 9 (60%) died after their second operative procedure.Logistic regression demonstrated that CAD [LR 7.5 p \u2009<\u20090.01 (95% CI 2.2 to 25.3)], and SA [LR 3.3 p \u2009=\u20090.03 (95% CI 1.1 to 10.1)], followed by age [LR 1.06 p \u2009=\u20090.042 (95% CI 1.00 to 1.12)], were risk factors for death in all patients (Table\xa05).']	death	GO_BP_EXT	[18967]	[18972]	PMC1852384_T88
PMC1852384	PMC1852384_102	[19000]	[19122]	['Although a small sample set, 12.7% of patients with CAD died (7/55) and 29% of patients with BMI\u2009>\u200950 and CAD and SA died.']	died	GO_BP_EXT	[19056]	[19060]	PMC1852384_T89
PMC1852384	PMC1852384_102	[19000]	[19122]	['Although a small sample set, 12.7% of patients with CAD died (7/55) and 29% of patients with BMI\u2009>\u200950 and CAD and SA died.']	died	GO_BP_EXT	[19117]	[19121]	PMC1852384_T90
PMC1852384	PMC1852384_103	[19124]	[19714]	['Caption (TABLE-WRAP): TABLE\xa05\n\nLogistic Regression Evaluation of Patient Comorbidity as Predictors of Mortality\xa0 p -ValueRelative Risk95% Confidence IntervalAge0.0421.0591.002–1.120BMI0.1301.0250.993–1.058Female0.6120.7290.215–2.474DM0.8520.8890.259–3.054HTN0.2572.0850.585–7.438CAD0.0017.4462.195–25.258Dyslipidemia0.0990.3590.106–1.211Asthma0.0703.0650.913–10.293SA0.0333.3421.104–10.115SOB0.6930.6440.073–5.725Although the average BMI of males was slightly greater than that of females (55.2 vs 51.2\xa0kg/m2, p \u2009<\u20090.01), the two populations also differed in characteristics other than BMI.']	Mortality	GO_BP_EXT	[19226]	[19235]	PMC1852384_T91
PMC1852384	PMC1852384_103	[19124]	[19714]	['Caption (TABLE-WRAP): TABLE\xa05\n\nLogistic Regression Evaluation of Patient Comorbidity as Predictors of Mortality\xa0 p -ValueRelative Risk95% Confidence IntervalAge0.0421.0591.002–1.120BMI0.1301.0250.993–1.058Female0.6120.7290.215–2.474DM0.8520.8890.259–3.054HTN0.2572.0850.585–7.438CAD0.0017.4462.195–25.258Dyslipidemia0.0990.3590.106–1.211Asthma0.0703.0650.913–10.293SA0.0333.3421.104–10.115SOB0.6930.6440.073–5.725Although the average BMI of males was slightly greater than that of females (55.2 vs 51.2\xa0kg/m2, p \u2009<\u20090.01), the two populations also differed in characteristics other than BMI.']	males	UBERON_EXT	[19565]	[19570]	PMC1852384_T250
PMC1852384	PMC1852384_103	[19124]	[19714]	['Caption (TABLE-WRAP): TABLE\xa05\n\nLogistic Regression Evaluation of Patient Comorbidity as Predictors of Mortality\xa0 p -ValueRelative Risk95% Confidence IntervalAge0.0421.0591.002–1.120BMI0.1301.0250.993–1.058Female0.6120.7290.215–2.474DM0.8520.8890.259–3.054HTN0.2572.0850.585–7.438CAD0.0017.4462.195–25.258Dyslipidemia0.0990.3590.106–1.211Asthma0.0703.0650.913–10.293SA0.0333.3421.104–10.115SOB0.6930.6440.073–5.725Although the average BMI of males was slightly greater than that of females (55.2 vs 51.2\xa0kg/m2, p \u2009<\u20090.01), the two populations also differed in characteristics other than BMI.']	females	UBERON_EXT	[19605]	[19612]	PMC1852384_T251
PMC1852384	PMC1852384_104	[19715]	[19824]	['The male population had a significantly significant greater prevalence of DM, HTN, CAD, dyslipidemia, and SA.']	male	UBERON_EXT	[19719]	[19723]	PMC1852384_T252
PMC1852384	PMC1852384_105	[19825]	[20129]	['Females had a greater prevalence of pulmonary comorbidities, including asthma and dyspnea on exertion (Table\xa02).When logistic regression was performed specific to the subsets of sex, males with angiographically demonstrated CAD were 30 times more likely to die [LR 30.1 p \u2009=\u20090.028 (95% CI 1.4 to 631.4)].']	Females	UBERON_EXT	[19825]	[19832]	PMC1852384_T253
PMC1852384	PMC1852384_105	[19825]	[20129]	['Females had a greater prevalence of pulmonary comorbidities, including asthma and dyspnea on exertion (Table\xa02).When logistic regression was performed specific to the subsets of sex, males with angiographically demonstrated CAD were 30 times more likely to die [LR 30.1 p \u2009=\u20090.028 (95% CI 1.4 to 631.4)].']	pulmonary	UBERON_EXT	[19861]	[19870]	PMC1852384_T254
PMC1852384	PMC1852384_105	[19825]	[20129]	['Females had a greater prevalence of pulmonary comorbidities, including asthma and dyspnea on exertion (Table\xa02).When logistic regression was performed specific to the subsets of sex, males with angiographically demonstrated CAD were 30 times more likely to die [LR 30.1 p \u2009=\u20090.028 (95% CI 1.4 to 631.4)].']	males	UBERON_EXT	[20008]	[20013]	PMC1852384_T255
PMC1852384	PMC1852384_105	[19825]	[20129]	['Females had a greater prevalence of pulmonary comorbidities, including asthma and dyspnea on exertion (Table\xa02).When logistic regression was performed specific to the subsets of sex, males with angiographically demonstrated CAD were 30 times more likely to die [LR 30.1 p \u2009=\u20090.028 (95% CI 1.4 to 631.4)].']	die	GO_BP_EXT	[20082]	[20085]	PMC1852384_T92
PMC1852384	PMC1852384_106	[20130]	[20237]	['Logistic regression did not identify CAD as a significant predictor when the analysis was limited to women.']	women	NCBITAXON_EXT	[20231]	[20236]	PMC1852384_T128
PMC1852384	PMC1852384_106	[20130]	[20237]	['Logistic regression did not identify CAD as a significant predictor when the analysis was limited to women.']	women	UBERON_EXT	[20231]	[20236]	PMC1852384_T256
PMC1852384	PMC1852384_107	[20238]	[20421]	['Predictors of death for women include age [LR 1.07 p \u2009=\u20090.033 (95 % CI 1.0 to 1.14) and SA [LR 4.1 p \u2009=\u20090.040 (95% CI 1.07 to 16.2)].Logistic regression was repeated specific to race.']	death	GO_BP_EXT	[20252]	[20257]	PMC1852384_T93
PMC1852384	PMC1852384_107	[20238]	[20421]	['Predictors of death for women include age [LR 1.07 p \u2009=\u20090.033 (95 % CI 1.0 to 1.14) and SA [LR 4.1 p \u2009=\u20090.040 (95% CI 1.07 to 16.2)].Logistic regression was repeated specific to race.']	women	NCBITAXON_EXT	[20262]	[20267]	PMC1852384_T129
PMC1852384	PMC1852384_107	[20238]	[20421]	['Predictors of death for women include age [LR 1.07 p \u2009=\u20090.033 (95 % CI 1.0 to 1.14) and SA [LR 4.1 p \u2009=\u20090.040 (95% CI 1.07 to 16.2)].Logistic regression was repeated specific to race.']	women	UBERON_EXT	[20262]	[20267]	PMC1852384_T257
PMC1852384	PMC1852384_108	[20422]	[20592]	['When limited to Caucasian patients only, Caucasians with CAD were 58 times more likely to die [LR 58.8 p \u2009<\u20090.01 (95% CI 4.8 to 716.9)] than those Caucasians without CAD.']	die	GO_BP_EXT	[20512]	[20515]	PMC1852384_T94
PMC1852384	PMC1852384_113	[20890]	[21210]	['One-way ANOVA did not demonstrate any significant differences in prevalence of death or CAD between the three racial groups for the entire population or specific to sex.Hispanic patients had significantly less SA than either the Caucasian or African–American patients (18.1 vs 25.6 and 27.4%, respectively ( p \u2009=\u20090.01)).']	death	GO_BP_EXT	[20969]	[20974]	PMC1852384_T95
PMC1852384	PMC1852384_114	[21211]	[21320]	['When examined specifically in relation to sex, there were no differences among prevalence of SA in the males.']	males	UBERON_EXT	[21314]	[21319]	PMC1852384_T258
PMC1852384	PMC1852384_115	[21321]	[21466]	['African–American women, however, had the greatest prevalence of SA (26.4%) compared to Caucasian (18.9%) and Hispanic (15.7%) women ( p \u2009<\u20090.01).']	women	NCBITAXON_EXT	[21338]	[21343]	PMC1852384_T130
PMC1852384	PMC1852384_115	[21321]	[21466]	['African–American women, however, had the greatest prevalence of SA (26.4%) compared to Caucasian (18.9%) and Hispanic (15.7%) women ( p \u2009<\u20090.01).']	women	UBERON_EXT	[21338]	[21343]	PMC1852384_T259
PMC1852384	PMC1852384_115	[21321]	[21466]	['African–American women, however, had the greatest prevalence of SA (26.4%) compared to Caucasian (18.9%) and Hispanic (15.7%) women ( p \u2009<\u20090.01).']	women	NCBITAXON_EXT	[21447]	[21452]	PMC1852384_T131
PMC1852384	PMC1852384_115	[21321]	[21466]	['African–American women, however, had the greatest prevalence of SA (26.4%) compared to Caucasian (18.9%) and Hispanic (15.7%) women ( p \u2009<\u20090.01).']	women	UBERON_EXT	[21447]	[21452]	PMC1852384_T260
PMC1852384	PMC1852384_116	[21468]	[21685]	['Discussion\nThe tremendous growth of bariatric surgery over the past several years has spawned much interest in its complications and mortality, first in the media, but most recently in the public health arena as well.']	bariatric	UBERON_EXT	[21504]	[21513]	PMC1852384_T261
PMC1852384	PMC1852384_117	[21686]	[21867]	['Health and malpractice insurance carriers as well as governmental agencies and professional societies are evaluating the risks of bariatric surgery and the surgeons that perform it.']	bariatric	UBERON_EXT	[21816]	[21825]	PMC1852384_T262
PMC1852384	PMC1852384_118	[21868]	[22048]	['In several states, insurance companies have stopped covering bariatric surgery at the same time that the Centers for Medicare and Medicaid Services have approved coverage for them.']	bariatric	UBERON_EXT	[21929]	[21938]	PMC1852384_T263
PMC1852384	PMC1852384_119	[22049]	[22311]	['Several malpractice carriers have stopped issuing policies for surgeons performing bariatric procedures while others are categorizing bariatric surgery as a high-risk subspecialty area, similar to obstetrics and neurosurgery, and increasing premiums accordingly.']	bariatric	UBERON_EXT	[22132]	[22141]	PMC1852384_T264
PMC1852384	PMC1852384_119	[22049]	[22311]	['Several malpractice carriers have stopped issuing policies for surgeons performing bariatric procedures while others are categorizing bariatric surgery as a high-risk subspecialty area, similar to obstetrics and neurosurgery, and increasing premiums accordingly.']	bariatric	UBERON_EXT	[22183]	[22192]	PMC1852384_T265
PMC1852384	PMC1852384_121	[22462]	[22812]	['Much of the information being utilized in this regard has come form series utilizing pooled data from multiple smaller series or government databases.1,5–9Buchwald et al.5performed a metaanalysis of 16,944 patients which included 7,074 patients that underwent gastric bypass (open and laparoscopic) in 44 studies with a 30-day mortality rate of 0.5%.']	gastric	UBERON_EXT	[22722]	[22729]	PMC1852384_T266
PMC1852384	PMC1852384_122	[22813]	[23298]	['Several authors have reported that complication rates of bariatric surgery were inversely correlated with case loads, reporting mortality rates of in the range of 0.1–0.5% for surgeons more than 100 or 150 cases per year.6–8Flum et al.9recently reported 30- and 90-day mortality rates of 2.0 and 2.8%, respectively in Medicare beneficiaries having bariatric surgery, with men having higher rates than women and those over 65\xa0years of age having higher rates than those younger than 65.']	men	UBERON_EXT	[23185]	[23188]	PMC1852384_T267
PMC1852384	PMC1852384_122	[22813]	[23298]	['Several authors have reported that complication rates of bariatric surgery were inversely correlated with case loads, reporting mortality rates of in the range of 0.1–0.5% for surgeons more than 100 or 150 cases per year.6–8Flum et al.9recently reported 30- and 90-day mortality rates of 2.0 and 2.8%, respectively in Medicare beneficiaries having bariatric surgery, with men having higher rates than women and those over 65\xa0years of age having higher rates than those younger than 65.']	women	NCBITAXON_EXT	[23214]	[23219]	PMC1852384_T132
PMC1852384	PMC1852384_126	[23655]	[23763]	['The results of these pooled series differ from those in several large series of open gastric bypasses2,3,11.']	gastric	UBERON_EXT	[23740]	[23747]	PMC1852384_T268
PMC1852384	PMC1852384_129	[24016]	[24200]	['Only male sex was predictive of severe life-threatening complications; mortality in patients over 55\xa0years was significantly greater than in patients under 55 (3.5 vs 1.1%, p \u2009<\u20090.05).']	male	UBERON_EXT	[24021]	[24025]	PMC1852384_T269
PMC1852384	PMC1852384_129	[24016]	[24200]	['Only male sex was predictive of severe life-threatening complications; mortality in patients over 55\xa0years was significantly greater than in patients under 55 (3.5 vs 1.1%, p \u2009<\u20090.05).']	life	UBERON_EXT	[24055]	[24059]	PMC1852384_T270
PMC1852384	PMC1852384_130	[24201]	[24444]	['More recently, Fernandez et al.3analyzed their patient cohort of 1,431 patients having open RYGB and found a 1.9% mortality, which was associated with age, weight, longer limb gastric bypass, and the occurrence of a leak or pulmonary embolism.']	limb	UBERON_EXT	[24372]	[24376]	PMC1852384_T271
PMC1852384	PMC1852384_130	[24201]	[24444]	['More recently, Fernandez et al.3analyzed their patient cohort of 1,431 patients having open RYGB and found a 1.9% mortality, which was associated with age, weight, longer limb gastric bypass, and the occurrence of a leak or pulmonary embolism.']	gastric	UBERON_EXT	[24377]	[24384]	PMC1852384_T272
PMC1852384	PMC1852384_130	[24201]	[24444]	['More recently, Fernandez et al.3analyzed their patient cohort of 1,431 patients having open RYGB and found a 1.9% mortality, which was associated with age, weight, longer limb gastric bypass, and the occurrence of a leak or pulmonary embolism.']	pulmonary	UBERON_EXT	[24425]	[24434]	PMC1852384_T273
PMC1852384	PMC1852384_132	[24609]	[24792]	['In both of these series, the BMI was higher, the patients were older and the incidence of serious comorbidities, such as diabetes, hypertension, dyslipidemia, and sleep apnea, higher.']	sleep	GO_BP_EXT	[24772]	[24777]	PMC1852384_T96
PMC1852384	PMC1852384_133	[24793]	[24944]	['Pories et al.11reported a 1.5% perioperative mortality rate, with 0.8% dying of sepsis, 0.5% dying of pulmonary embolism, and 0.2% of an unknown cause.']	dying	GO_BP_EXT	[24864]	[24869]	PMC1852384_T97
PMC1852384	PMC1852384_133	[24793]	[24944]	['Pories et al.11reported a 1.5% perioperative mortality rate, with 0.8% dying of sepsis, 0.5% dying of pulmonary embolism, and 0.2% of an unknown cause.']	dying	GO_BP_EXT	[24886]	[24891]	PMC1852384_T98
PMC1852384	PMC1852384_134	[24945]	[25112]	['Additional information regarding the incidence of leaks, bowel obstructions and other complications was not reported as these were not the focus of the original paper.']	bowel	UBERON_EXT	[25002]	[25007]	PMC1852384_T274
PMC1852384	PMC1852384_136	[25229]	[25498]	['The prevalence of preoperative comorbidities was comparable to the larger series (diabetes—23%, hypertension—39%, dyslipidemia—46%, coronary artery disease/congestive heart failure—5.5%, sleep apnea—23.5%, and asthma—15%) and generally higher than in the pooled series.']	coronary artery	UBERON_EXT	[25361]	[25376]	PMC1852384_T275
PMC1852384	PMC1852384_137	[25499]	[25613]	['The incidence of leaks and postoperative small bowel obstruction in our series was comparable to the other series.']	small bowel	UBERON_EXT	[25540]	[25551]	PMC1852384_T276
PMC1852384	PMC1852384_138	[25614]	[25823]	['The incidence of pulmonary embolism was less than those reported, perhaps related to the use of both pneumatic compression stockings and subcutaneous heparin and early ambulation with a shorter length of stay.']	pulmonary	UBERON_EXT	[25631]	[25640]	PMC1852384_T277
PMC1852384	PMC1852384_138	[25614]	[25823]	['The incidence of pulmonary embolism was less than those reported, perhaps related to the use of both pneumatic compression stockings and subcutaneous heparin and early ambulation with a shorter length of stay.']	subcutaneous	UBERON_EXT	[25751]	[25763]	PMC1852384_T278
PMC1852384	PMC1852384_138	[25614]	[25823]	['The incidence of pulmonary embolism was less than those reported, perhaps related to the use of both pneumatic compression stockings and subcutaneous heparin and early ambulation with a shorter length of stay.']	heparin	CHEBI_EXT	[25764]	[25771]	PMC1852384_T45
PMC1852384	PMC1852384_138	[25614]	[25823]	['The incidence of pulmonary embolism was less than those reported, perhaps related to the use of both pneumatic compression stockings and subcutaneous heparin and early ambulation with a shorter length of stay.']	ambulation	GO_BP_EXT	[25782]	[25792]	PMC1852384_T99
PMC1852384	PMC1852384_140	[25953]	[26023]	['Multisystem organ failure accounted for 11 deaths in our series (73%).']	Multisystem	UBERON_EXT	[25953]	[25964]	PMC1852384_T279
PMC1852384	PMC1852384_140	[25953]	[26023]	['Multisystem organ failure accounted for 11 deaths in our series (73%).']	organ	UBERON_EXT	[25965]	[25970]	PMC1852384_T280
PMC1852384	PMC1852384_140	[25953]	[26023]	['Multisystem organ failure accounted for 11 deaths in our series (73%).']	deaths	GO_BP_EXT	[25996]	[26002]	PMC1852384_T100
PMC1852384	PMC1852384_141	[26024]	[26219]	['In six patients, this resulted from leaks or perforations; in one it followed a bowel obstruction, in two it followed postoperative hemorrhage and in two patients, the cause was never determined.']	bowel	UBERON_EXT	[26104]	[26109]	PMC1852384_T281
PMC1852384	PMC1852384_144	[26506]	[26780]	['To our knowledge, this “syndrome” has not been reported, but may be due to the fact that the enormous adipose tissue stores in these patients may act as a “metabolic sink”, releasing cytokines and other mediators and perpetuating this extreme systemic inflammatory response.']	adipose tissue	UBERON_EXT	[26608]	[26622]	PMC1852384_T282
PMC1852384	PMC1852384_144	[26506]	[26780]	['To our knowledge, this “syndrome” has not been reported, but may be due to the fact that the enormous adipose tissue stores in these patients may act as a “metabolic sink”, releasing cytokines and other mediators and perpetuating this extreme systemic inflammatory response.']	metabolic	GO_BP_EXT	[26662]	[26671]	PMC1852384_T101
PMC1852384	PMC1852384_144	[26506]	[26780]	['To our knowledge, this “syndrome” has not been reported, but may be due to the fact that the enormous adipose tissue stores in these patients may act as a “metabolic sink”, releasing cytokines and other mediators and perpetuating this extreme systemic inflammatory response.']	releasing	GO_BP_EXT	[26679]	[26688]	PMC1852384_T102
PMC1852384	PMC1852384_144	[26506]	[26780]	['To our knowledge, this “syndrome” has not been reported, but may be due to the fact that the enormous adipose tissue stores in these patients may act as a “metabolic sink”, releasing cytokines and other mediators and perpetuating this extreme systemic inflammatory response.']	cytokines	GO_MF_EXT	[26689]	[26698]	PMC1852384_T113
PMC1852384	PMC1852384_144	[26506]	[26780]	['To our knowledge, this “syndrome” has not been reported, but may be due to the fact that the enormous adipose tissue stores in these patients may act as a “metabolic sink”, releasing cytokines and other mediators and perpetuating this extreme systemic inflammatory response.']	mediators	CHEBI_EXT	[26709]	[26718]	PMC1852384_T46
PMC1852384	PMC1852384_144	[26506]	[26780]	['To our knowledge, this “syndrome” has not been reported, but may be due to the fact that the enormous adipose tissue stores in these patients may act as a “metabolic sink”, releasing cytokines and other mediators and perpetuating this extreme systemic inflammatory response.']	inflammatory	GO_BP_EXT	[26758]	[26770]	PMC1852384_T103
PMC1852384	PMC1852384_144	[26506]	[26780]	['To our knowledge, this “syndrome” has not been reported, but may be due to the fact that the enormous adipose tissue stores in these patients may act as a “metabolic sink”, releasing cytokines and other mediators and perpetuating this extreme systemic inflammatory response.']	response	GO_BP_EXT	[26771]	[26779]	PMC1852384_T104
PMC1852384	PMC1852384_145	[26781]	[26909]	['Two of the deaths were due to fatal arrhythmias, both in patients with known CAD, who were extensively evaluated preoperatively.']	deaths	GO_BP_EXT	[26792]	[26798]	PMC1852384_T105
PMC1852384	PMC1852384_145	[26781]	[26909]	['Two of the deaths were due to fatal arrhythmias, both in patients with known CAD, who were extensively evaluated preoperatively.']	fatal	GO_BP_EXT	[26811]	[26816]	PMC1852384_T106
PMC1852384	PMC1852384_146	[26910]	[27087]	['The death due to pulmonary embolism occurred after discharge, even though the patient received prophylaxis with both heparin and pneumatic compression stockings in the hospital.']	death	GO_BP_EXT	[26914]	[26919]	PMC1852384_T107
PMC1852384	PMC1852384_146	[26910]	[27087]	['The death due to pulmonary embolism occurred after discharge, even though the patient received prophylaxis with both heparin and pneumatic compression stockings in the hospital.']	pulmonary	UBERON_EXT	[26927]	[26936]	PMC1852384_T283
PMC1852384	PMC1852384_146	[26910]	[27087]	['The death due to pulmonary embolism occurred after discharge, even though the patient received prophylaxis with both heparin and pneumatic compression stockings in the hospital.']	heparin	CHEBI_EXT	[27027]	[27034]	PMC1852384_T47
PMC1852384	PMC1852384_147	[27088]	[27154]	['The remaining death due to exsanguination was clearly preventable.']	death	GO_BP_EXT	[27102]	[27107]	PMC1852384_T108
PMC1852384	PMC1852384_148	[27155]	[27279]	['Although males were significantly heavier and had higher BMIs than women, sex was not an independent predictor of morbidity.']	males	UBERON_EXT	[27164]	[27169]	PMC1852384_T284
PMC1852384	PMC1852384_148	[27155]	[27279]	['Although males were significantly heavier and had higher BMIs than women, sex was not an independent predictor of morbidity.']	women	NCBITAXON_EXT	[27222]	[27227]	PMC1852384_T133
PMC1852384	PMC1852384_148	[27155]	[27279]	['Although males were significantly heavier and had higher BMIs than women, sex was not an independent predictor of morbidity.']	women	UBERON_EXT	[27222]	[27227]	PMC1852384_T285
PMC1852384	PMC1852384_149	[27280]	[27389]	['However, the presence of angiographically documented coronary artery disease was particularly ominous in men.']	coronary artery	UBERON_EXT	[27333]	[27348]	PMC1852384_T286
PMC1852384	PMC1852384_149	[27280]	[27389]	['However, the presence of angiographically documented coronary artery disease was particularly ominous in men.']	men	NCBITAXON_EXT	[27385]	[27388]	PMC1852384_T134
PMC1852384	PMC1852384_149	[27280]	[27389]	['However, the presence of angiographically documented coronary artery disease was particularly ominous in men.']	men	UBERON_EXT	[27385]	[27388]	PMC1852384_T287
PMC1852384	PMC1852384_150	[27390]	[27468]	['Males with angiographically demonstrated CAD were 30 times more likely to die.']	Males	UBERON_EXT	[27390]	[27395]	PMC1852384_T288
PMC1852384	PMC1852384_150	[27390]	[27468]	['Males with angiographically demonstrated CAD were 30 times more likely to die.']	die	GO_BP_EXT	[27464]	[27467]	PMC1852384_T109
PMC1852384	PMC1852384_151	[27469]	[27532]	['In women, predictors of death included age and SA, but not CAD.']	women	NCBITAXON_EXT	[27472]	[27477]	PMC1852384_T135
PMC1852384	PMC1852384_151	[27469]	[27532]	['In women, predictors of death included age and SA, but not CAD.']	women	UBERON_EXT	[27472]	[27477]	PMC1852384_T289
PMC1852384	PMC1852384_151	[27469]	[27532]	['In women, predictors of death included age and SA, but not CAD.']	death	GO_BP_EXT	[27493]	[27498]	PMC1852384_T110
PMC1852384	PMC1852384_152	[27533]	[27669]	['With respect to race, Caucasian males with BMI\u2009>\u200950 and CAD were most likely to die, whereas SA was a predictor in African–American men.']	males	UBERON_EXT	[27565]	[27570]	PMC1852384_T290
PMC1852384	PMC1852384_152	[27533]	[27669]	['With respect to race, Caucasian males with BMI\u2009>\u200950 and CAD were most likely to die, whereas SA was a predictor in African–American men.']	die	GO_BP_EXT	[27613]	[27616]	PMC1852384_T111
PMC1852384	PMC1852384_152	[27533]	[27669]	['With respect to race, Caucasian males with BMI\u2009>\u200950 and CAD were most likely to die, whereas SA was a predictor in African–American men.']	men	NCBITAXON_EXT	[27665]	[27668]	PMC1852384_T136
PMC1852384	PMC1852384_152	[27533]	[27669]	['With respect to race, Caucasian males with BMI\u2009>\u200950 and CAD were most likely to die, whereas SA was a predictor in African–American men.']	men	UBERON_EXT	[27665]	[27668]	PMC1852384_T291
PMC1852384	PMC1852384_154	[27709]	[27928]	['Despite the increased mortality in Caucasian males with CAD, these patients were not candidates for cardiac revascularization and extreme weight loss was the only intervention thought to make a beneficial health impact.']	males	UBERON_EXT	[27754]	[27759]	PMC1852384_T292
PMC1852384	PMC1852384_154	[27709]	[27928]	['Despite the increased mortality in Caucasian males with CAD, these patients were not candidates for cardiac revascularization and extreme weight loss was the only intervention thought to make a beneficial health impact.']	cardiac	UBERON_EXT	[27809]	[27816]	PMC1852384_T293
PMC1852384	PMC1852384_156	[28039]	[28191]	['Risk appears to be adversely affected by increasing BMI and those factors with which it is often associated namely male sex and coronary artery disease.']	male	UBERON_EXT	[28154]	[28158]	PMC1852384_T294
PMC1852384	PMC1852384_156	[28039]	[28191]	['Risk appears to be adversely affected by increasing BMI and those factors with which it is often associated namely male sex and coronary artery disease.']	coronary artery	UBERON_EXT	[28167]	[28182]	PMC1852384_T295
PMC1852384	PMC1852384_159	[28568]	[29060]	['For example, perioperative mortality after elective surgery for abdominal aortic aneurysms has been reported at 3.1–4.7% overall, 1.0–2.7% in patients under 65\xa0years of age, and 3.5–5.2% in patients over 65\xa0years of age.12Using Medicare data adjusted for high volume surgeons, Birkmeyer et al.13reported perioperative mortality rates of 4.5% for colectomy, 8.6% for gastrectomy, 8.4% for esophagectomy, 3.8% for pancreatic resection, 4.0% for pulmonary lobectomy, and 10.7% for pneumonectomy.']	abdominal aortic aneurysms	UBERON_EXT	[28632]	[28658]	PMC1852384_T296
PMC1852384	PMC1852384_159	[28568]	[29060]	['For example, perioperative mortality after elective surgery for abdominal aortic aneurysms has been reported at 3.1–4.7% overall, 1.0–2.7% in patients under 65\xa0years of age, and 3.5–5.2% in patients over 65\xa0years of age.12Using Medicare data adjusted for high volume surgeons, Birkmeyer et al.13reported perioperative mortality rates of 4.5% for colectomy, 8.6% for gastrectomy, 8.4% for esophagectomy, 3.8% for pancreatic resection, 4.0% for pulmonary lobectomy, and 10.7% for pneumonectomy.']	pancreatic	UBERON_EXT	[28980]	[28990]	PMC1852384_T297
PMC1852384	PMC1852384_159	[28568]	[29060]	['For example, perioperative mortality after elective surgery for abdominal aortic aneurysms has been reported at 3.1–4.7% overall, 1.0–2.7% in patients under 65\xa0years of age, and 3.5–5.2% in patients over 65\xa0years of age.12Using Medicare data adjusted for high volume surgeons, Birkmeyer et al.13reported perioperative mortality rates of 4.5% for colectomy, 8.6% for gastrectomy, 8.4% for esophagectomy, 3.8% for pancreatic resection, 4.0% for pulmonary lobectomy, and 10.7% for pneumonectomy.']	pulmonary lobectomy	UBERON_EXT	[29011]	[29030]	PMC1852384_T298
PMC1852384	PMC1852384_161	[29472]	[29677]	['This is not meant to suggest that every effort should not be made to lessen the risks of bariatric surgery and to improve operative mortality, but rather to inject some proportionality into the discussion.']	bariatric	UBERON_EXT	[29561]	[29570]	PMC1852384_T299
PMC1852384	PMC1852384_166	[30598]	[30695]	['Age, coronary artery disease, and obstructive sleep apnea correlate with perioperative mortality.']	coronary artery	UBERON_EXT	[30603]	[30618]	PMC1852384_T300
